Vyripharm Biopharmaceuticals, Inc.
11
Jeffrey P Norman
01/27/2025
02/02/2026
Yes
v
| PlnDue, DsclsDue |
Assigned to: Bankruptcy Judge Jeffrey P Norman Chapter 11 Voluntary Asset |
|
Debtor Vyripharm Biopharmaceuticals, Inc.
7205 Almeda Road, Suite 300591 Houston, TX 77054 HARRIS-TX Tax ID / EIN: 85-4177026 |
represented by |
Susan Tran Adams
Tran Singh LLP 2502 La Branch Street Houston, TX 77004 832-975-7300 Fax : 832-975-7301 Email: stran@ts-llp.com |
Trustee Melissa A Haselden
Haselden Farrow PLLC Pennzoil Place 700 Milam Suite 1300 Houston, TX 77002 832.819.1149 |
| |
U.S. Trustee US Trustee
Office of the US Trustee 515 Rusk Ave Ste 3516 Houston, TX 77002 713-718-4650 |
represented by |
Hector Duran, Jr
U.S. Trustee 515 Rusk Ste 3516 Houston, Tx 77002 7137184650 Email: Hector.Duran.Jr@usdoj.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 02/02/2026 | 68 | Declaration re: Declaration of Mailing (Filed By Melissa A Haselden ).(Related document(s):[67] Notice) (Haselden, Melissa) |
| 01/29/2026 | 67 | Notice NOTICE OF FILING FIRST AND FINAL FEE APPLICATION OF MELISSA A. HASELDEN AND HASELDEN FARROW, PLLC. (Related document(s):[66] Application for Compensation) Filed by Melissa A Haselden (Haselden, Melissa) |
| 01/29/2026 | 66 | Final Application for Compensation for Melissa Anne Haselden, Trustee Chapter 11, Period: 1/29/2025 to 1/21/2026, Fee: $5,201.00, Expenses: $0.00. Objections/Request for Hearing Due in 21 days. Filed by Attorney Melissa Anne Haselden Hearing scheduled for 3/3/2026 at 11:00 AM at Houston, Courtroom 403 (JPN). (Attachments: # (1) Proposed Order) (Haselden, Melissa) |
| 01/29/2026 | 65 | Debtor-In-Possession Monthly Operating Report for Filing Period ending 12/31/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan) |
| 01/29/2026 | 64 | Debtor-In-Possession Monthly Operating Report for Filing Period ending 11/30/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan) |
| 01/23/2026 | 63 | BNC Certificate of Mailing. (Related document(s):[62] Order Dismissing Debtor(s)) No. of Notices: 5. Notice Date 01/23/2026. (Admin.) |
| 01/21/2026 | 62 | Order Dismissing Case Signed on 1/21/2026 (Related Document: [61] Agreed Motion to Dismiss) (trc4) |
| 01/21/2026 | 61 | Agreed Motion to Dismiss Bankruptcy Filed by Debtor Vyripharm Biopharmaceuticals, Inc. Hearing scheduled for 3/3/2026 at 11:00 AM at telephone and video conference. (Attachments: # (1) Proposed Order # (2) Service List) (Adams, Susan) |
| 01/05/2026 | 60 | Debtor-In-Possession Monthly Operating Report for Filing Period ending 10/31/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan) |
| 12/22/2025 | 59 | PDF with attached Audio File. Court Date & Time [ 12/22/2025 9:00:46 AM ]. File Size [ 1409 KB ]. Run Time [ 00:02:56 ]. (admin). |